Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer

AIM: To directly compare the efficacy and toxicity of standard-dose FOLFIRINOX (sFOLFIRINOX) and modified-dose FOLFIRINOX (mFOLFIRINOX, 75% of standard-dose) for pancreatic cancer. METHODS: One hundred and thirty pancreatic cancer patients who received sFOLFIRINOX (n = 88) or mFOLFIRINOX (n = 42) as...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Gastrointest Oncol
Hlavní autoři: Kang, Huapyong, Jo, Jung Hyun, Lee, Hee Seung, Chung, Moon Jae, Bang, Seungmin, Park, Seung Woo, Song, Si Young, Park, Jeong Youp
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2018
Témata:
Retrospective Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6247105/
https://ncbi.nlm.nih.gov/pubmed/30487953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v10.i11.421
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky